Two Bear Capital
VC Fund
Whitefish, United States
Two Bear Capital is a VC fund in Whitefish focused on Biotechnology and Software. Two Bear Capital invests in early-stage companies with disruptive innovations at the intersections of biotech, bioinformatics, machine learning / AI, and cybersecurity that deliver dramatically better solutions to the most critical problems affecting human health, security and wellness.
- Total investments:
- 43
- Last investment:
- Lead investor:
- 74%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Two Bear Capital invests in
Stages Two Bear Capital invests in
Countries Two Bear Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 10 contacts → | |||
Investment Focus
Industry
- Biotechnology 8 (19%)
- Software 6 (14%)
- Health Care 6 (14%)
- Information Technology 5 (12%)
- Artificial Intelligence 5 (12%)
Stage
- Series A 11 (26%)
- Seed 8 (19%)
- Series B 5 (12%)
- Funding Round 2 (5%)
- Convertible Note 2 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Bridget Martell
Biotechnology Operating Partner
|
Biotechnology Operating Partner | Total investments: 0 | Find email | |
Cris Neckar
Partner
|
Partner | Total investments: 4 | Find email | |
Jeff Miller
Operating Partner
|
Operating Partner | Total investments: 0 | Find email | |
Jenna (Garr) Aronson
Principle
|
Principle | Total investments: 2 | Find email | |
Jennifer Howrigan
VP, Investor Relations
|
VP, Investor Relations | Total investments: 0 | Find email | |
| See all 10 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Rainfall Health
|
Rainfall Health was established to help bridge the gap in providing access to quality healthcare in medical deserts. | $15M / Series A / Feb 18, 2026 | |
Selector
|
Selector AI is a platform for operational intelligence of multi-cloud infrastructure and performance-sensitive managed services. By adopting an AI/ML-based data analytics approach, Selector AI provides actionable multi-dimensional insights to network, cloud, and application operators. Their customers can meet their service KPIs throughseamless collaboration on messaging platforms, search-driven querying with a conversational user experience, and automated data engineering pipelines. | $32M / Series B / Feb 18, 2026 | |
Leapfrog Bio
|
Leapfrog Bio is developing targeted therapies for cancers caused by genetic mutations that are resistant to conventional treatment. The company was founded in 2019 and is headquartered in South San Francisco, California. | Seed / Jan 12, 2026 | |
Revenium
|
Revenium helps monetize AI workloads. It provides services to organizations to help them make AI usage governable and profitable. The platform provides real-time insights into AI usage and spend to help clients track trends and spikes in the financial sector. | $13.5M / Seed / Nov 20, 2025 | |
Conceal
|
NetAbstraction is a network engineering and cybersecurity firm intended to protect customer activities on the internet. | $26M / Series B / Oct 16, 2025 | |
FYR Diagnostics
|
FYR Diagnostics develops biomarker detection technology to combat chronic diseases in both human healthcare and agriculture. The company was founded in 2016 and is headquartered in Missoula, Montana. | $8M / Sep 24, 2025 | |
|
FYR Diagnostics
|
FYR Diagnostics develops biomarker detection technology to combat chronic diseases in both human healthcare and agriculture. The company was founded in 2016 and is headquartered in Missoula, Montana. | $8M / Sep 24, 2025 | |
Graphiant
|
Graphiant provides Network-as-a-Service solutions that enhance connectivity for AI, Cloud, and SaaS applications. The company focuses on delivering software-based, agentless solutions that integrate smoothly with existing systems. These services optimize performance for various workloads and accommodate diverse hardware setups. Graphiant aims tosimplify network deployment and scaling, ensuring that businesses can adapt to evolving connectivity needs. By offering a unified network solution, Graphiant supports organizations in navigating the complexities of modern digital environments. | $19M / Series B / May 19, 2025 | |
Montara Therapeutics
|
Montara Therapeutics is a biotechnology company. | $20M / Seed / Mar 13, 2025 | |
|
Montara Therapeutics
|
Montara Therapeutics is a biotechnology company. | $20M / Seed / Mar 13, 2025 | |
| See all 43 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Two Bear Capital invest in?
Two Bear Capital invests primarily in Biotechnology, Software and Health Care startups, most often at Series A and Seed stage. Most of the 43 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Two Bear Capital?
Public channels for Two Bear Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Two Bear Capital?
The team at Two Bear Capital includes Bridget Martell (Biotechnology Operating Partner), Cris Neckar (Partner) and Jeff Miller (Operating Partner), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
